In nutritional management of chronic lung disease, which therapy is considered most appropriate?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

In nutritional management of chronic lung disease, which therapy is considered most appropriate?

Explanation:
In chronic lung disease, meeting energy needs while keeping fluid load low is often the biggest challenge, because increased work of breathing and inflammation raise energy expenditure and patients may tolerate only small volumes. Providing a concentrated formula delivers more calories per milliliter, allowing adequate caloric intake without a high fluid load. This supports weight and nitrogen balance and can reduce dyspnea from large-volume feeds or edema, making it a practical first-line strategy. Other formulas have more specific indications. A high fat, low carbohydrate option can be helpful for reducing carbon dioxide production in some patients, but it isn’t universally suitable or necessary for all chronic lung disease cases. Hydrolyzed protein formulas are tailored for specific GI tolerance or malabsorption issues rather than general pulmonary nutrition. MCT oil–predominant formulas target particular fat digestion needs and are not a standard primary approach for most chronic lung disease patients.

In chronic lung disease, meeting energy needs while keeping fluid load low is often the biggest challenge, because increased work of breathing and inflammation raise energy expenditure and patients may tolerate only small volumes. Providing a concentrated formula delivers more calories per milliliter, allowing adequate caloric intake without a high fluid load. This supports weight and nitrogen balance and can reduce dyspnea from large-volume feeds or edema, making it a practical first-line strategy.

Other formulas have more specific indications. A high fat, low carbohydrate option can be helpful for reducing carbon dioxide production in some patients, but it isn’t universally suitable or necessary for all chronic lung disease cases. Hydrolyzed protein formulas are tailored for specific GI tolerance or malabsorption issues rather than general pulmonary nutrition. MCT oil–predominant formulas target particular fat digestion needs and are not a standard primary approach for most chronic lung disease patients.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy